2475 Mercer Avenue, Suite 101
West Palm Beach, FL 33401
Get FREE Consultation
561-570-7000
Contacts

The Connection Between HGH And Atherosclerosis

Written by Author - Authors Medical experts of the National HRT Clinic - April 27, 2016

Atherosclerosis and HGH

Experts confirm that there is a definite connection between human growth hormone (HGH) and atherosclerosis (a hardening of plaque within the arteries that can lead to heart attack and/or stroke). As a person ages, his or her growth hormone starts to deplete naturally. Some people experience such a strong and severe depletion of their growth hormone, that it leads to problems, including heart related issues such as atherosclerosis.

The Journal of Endocrinology and Metabolism has a plethora of research articles that have shown the connection between the vital hormone HGH and atherosclerosis. One study stated that HGH replacement can turn around some of the major risk factors that can bring upon atherosclerosis. The experts say that the vital hormone GH:

  1. Can reverse early morphological atherosclerotic changes in arteries
  2. Can reverse early operational atherosclerotic changes in arteries
  3. May reduce vascular morbidity
  4. May affect endothelial cell function

The study demonstrated that HGH treatment in men reduced instances of vascular problems. HGH treatment can increase and balance low growth hormone levels and helps to decrease LDL (bad) cholesterol levels. This has a direct effect on how the heart functions.

Journal of Endocrinology and Metabolism published another article that shared how HGH can reverse some of the most prevalent risk factors of atherosclerosis. Subjects underwent treatment lasting for 18 months. Half of the participants were given recombinant HGH and the other half were given a placebo. There wasn’t any change in the placebo group; however, the HGH treated group experienced noted improvement in early detection of changes in the arteries and reduction of vascular disease and death.

Can HGH Reverse Atherosclerosis?

Yes. Experts say that HGH treatment helps to reduce LDL (bad) cholesterol levels. High LDL cholesterol levels can lead to blocked blood flow to the heart or brain. The blood can become obstructed by fatty deposits (called plaque) that build up inside the walls of the arteries. This is called atherosclerosis. When enough blood cannot successfully get to the heart or brain, this can cause a heart attack or stroke.

However, since HGH treatment is available, a licensed doctor can prescribe and supervise the exact amount of HGH medication that a patient would need to take in order help lower LDL cholesterol levels. By reducing higher than normal LDL cholesterol levels in the blood, this can lead to a reduction or a prevention of the occurrence of atherosclerosis. A patient can be saved from the possibility of having a heart attack or stroke.

Has HGH For Atherosclerosis Saved Lives?

Yes. The Journal of Endocrinology and Metabolism has a plethora of articles that share that HGH treatment can in fact reduce the risk for developing atherosclerosis and has saved lives. An article published in the journal discussed growth hormone and cardiovascular risk factors. The results were clear:

  • Lack of growth hormone (a growth hormone deficiency) in an adult can lead to cardiovascular high risk problems
  • Data on HGH treatment reversing cardiovascular problems is highly encouraging
  • HGH treatment has many beneficial effects for the heart

The article advocates for HGH treatment for patients who are growth hormone deficient. These people may have some of the symptoms of the GH depletion, such as high LDL cholesterol levels.
A well known source shared that HGH is being considered a weapon against atherosclerosis. The experts say that by age 50 for many, there is no longer any growth hormone being produced naturally by the pituitary gland in the body. This is when symptoms will surface and HGH treatment can help.

Since HGH has been proven in studies to lower LDL cholesterol levels, decrease weight (body fat) and lower the risk for the formation of plaque build up in the arteries (atherosclerosis), it is gaining more and more popularity amongst more traditional doctors. More physicians who once would have never considered using HGH for help with heart related problems are now prescribing it for their patients.

The experts say that the best way to take HGH medication is through properly prescribed HGH injections. Oral forms of HGH will not lower the risk for atherosclerosis or reduce the disease. Oral HGH is ingested and metabolized by the stomach’s acids once the medication reaches that area. In addition, there is usually not enough of the medication in pills, sprays or drops to make a difference in the first place.

In conclusion, since HGH has been proven to increase blood circulation (clearing arteries for easier blood flow), it can reverse the disease of atherosclerosis. This can decrease the possibility of heart attack, stroke or other cardiovascular problems and increase quality of life in general with other benefits as well.

For more information about HGH atherosclerosis, please reach out to our experts who will be happy to answer any and all of your questions. We have an easy to fill out online contact form for your convenience or you can call us directly during normal business hours. We are here to help you increase your quality of life and to possibly save your life from the dangers of atherosclerosis.

Medically reviewed by   Reviewers National HRT Staff - Updated on November 4, 2024

Please note that the information provided in this article is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment.

References

  1. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.J Clin Endocrinol Metab. 1999 Feb;84(2):453-7.
  2. Growth hormone (GH) and atherosclerosis: changes in morphology and function of major arteries during GH treatment Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN.
  3. Growth Hormone Treatment on Atherosclerosis: Results of a 5-Year Open, Prospective, Controlled Study in Male Patients with Severe Growth Hormone Deficiency Pfeifer Verhovec R, Zizek B.Growth Horm IGF Res. 1999 Apr;9 Suppl A:25-30
  4. ezinearticles.com
  5. Merk Manuals Consumer Version
  6. Colao, A, Marzullo, P, Di Somma, C, and Lombardi, G. Growth hormone and the heart. Clin Endocrinol (Oxf). 2001; 54: 137–154
  7. Pfeifer, M, Verhovec, R, Zizek, B, Prezelj, J, Poredos, P, and Clayton, RN. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab. 1999; 84: 453–457
  8. Johannsson, G, Bengtsson, BA, Andersson, B, Isgaard, J, and Caidahl, K. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults: preliminary data in a small group of patients. Clin Endocrinol (Oxf). 1996; 45: 305–314
  9. Caidahl, K, Eden, S, and Bengtsson, BA. Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf). 1994; 40: 393–400
  10. Yang, R, Bunting, S, Gillett, N, Clark, R, and Jin, H. Growth hormone improves cardiac performance in experimental heart failure. Circulation. 1995; 92: 262–267
  11. Duerr, RL, Huang, S, Miraliakbar, HR, Clark, R, Chien, KR, and Ross, J Jr. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995; 95: 619–627
  12. Osterziel, KJ, Strohm, O, Schuler, J et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet. 1998; 351: 1233–1237
  13. Isgaard, J, Bergh, CH, Caidahl, K, Lomsky, M, Hjalmarson, A, and Bengtsson, BA. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J. 1998; 19: 1704–1711
  14. mit, JW, Janssen, YJ, Lamb, HJ et al. Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab. 2001; 86: 4638–4643
  15. Cuneo, RC, Wilmshurst, P, Lowy, C, McGauley, G, and Sonksen, PH. Cardiac failure responding to growth hormone [letter]. Lancet. 1989; 1: 838–839